Global telemedicine market can be estimated at the level of USD 60.2 billion in 2019 and is expected to exceed USD 162 billion by 2025, growing at a CAGR of 17.6% over the forecast period.
This research is a marketing analysis of the global telemedicine market in the world. A forecast of the market development until 2025 has been made by analysts with analysis of the market since 2018.
There are three key segments which are Electronic Health Records (EHR), Interactive Telemedicine, Remote Patient Monitoring (RPM).
The EHR segment dominates the telemedicine market, with almost 42% market share in the revenue. The EHR market will be analyzed separately in one of the next chapters of the given research.
Interactive Telemedicine has 36% revenue market share, and Remote Patient Monitoring (RPM) has 22% revenue market share. COVID-19 has contributed to the increasing tendency of the use of telemedicine apartment.
Research tasks:
State description of the global telemedicine market
Assessment of the global telemedicine market capacity
Global telemedicine market segmentation
Description of the main competitors
Assessment of the market development prospects
Analysis of the COVID-19 impacts on the industry
Making a forecast of the market development until 2025
The report would help leaders/new entrants in this market in the following ways:
This report comprehensively segments the telemedicine market and provides the closest market size projection.
The report reveals the tendencies of the market and provides them with information on key factors, limitations, problems, and opportunities for market growth.
This report would help stakeholders better understand their competitors and get more insights to improve their business position.
The report allows end-users to better understand what solutions exist in the telemedicine market for their industries and help them choose a supplier of appropriate solutions.
Key Topics Covered:
Chapter 1: Telemedicine market - global market review
1.1. History of telemedicine services
1.2. Telemedicine: technology and service description
1.3. Global telemedicine market size
1.4. Telemedicine market drivers
1.5. Top Telemedicine Medical Specialties
Chapter 2: Telemedicine Services Market (excluding EHR Market)
2.1. Level of Telemedicine Services Usage in Different Countries
2.2. Telemedicine Services in Key Markets
2.2.1. The Americas: the USA
2.2.2. European Region: the EU and Others
2.2.3. Asia Pacific: China
2.2.4. MENA Region: the Kingdom of Saudi Arabia
2.2.5. Southern Asia: India
Chapter 3: Global Electronic Health Records (EHR) Market
3.1. EHR Market Overview
3.2. Legislative Framework of EHR Market Development
3.2.1. The USA
3.2.2. The European Union
3.2.3. Other Countries
3.3. Global EHR Market Segmentation
3.3.1. By Geographical Region/Country
3.3.2. By Product
3.3.3. By End User
3.3.4. By Application
3.3.5. By Vendor
Chapter 4: Global Telemedicine Equipment Market
4.1. Telemedicine Equipment Market Size
4.2. Telemedicine Equipment Market Segments
Chapter 5: Competitive Landscape
5.1. Non-Profit Telemedicine Associations
5.2. Key Telemedicine Market Players
5.3. Company Profiles
Chapter 6: Summary and Conclusions
Companies Mentioned
Aerotel Medical Systems Ltd.
Allscripts Healthcare Solutions Inc.
AMD Global Telemedicine Inc.
American Telemedicine Association (the ATA)
Amwell Corporation
Athenahealth Inc.
BioTelemetry Inc.
Cerner Corporation
CompuGroup Medical SE & Co. KGaA
Doctor on Demand
eClinicalWorks
Epic Systems Corporation
GE Healthcare
Greenway Health
International Society for Telemedicine and eHealth (the ISfTeH)
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...
The First Bancshares, Inc. ("FBMS" or "the Company") , holding company for The First Bank, (www.thefirstbank.com) reported today financial results for the quarter ended March 31, 2024.
Highlights for the Quarter:
Net income available to common...
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in thedevelopment oftherapeutics for age-related...
Alamos Gold Inc. ("Alamos" or the "Company") today reported its financial results for the quarter ended March 31, 2024. "We delivered another strong start to the year across a number of fronts, following a record performance in 2023. Costs...
Ball Corporation's board of directors (the "Board") today declared a cash dividend of 20 cents per share, payable June 17, 2024, to shareholders of record as of June 3, 2024. In addition, the board also approved the repurchase by the company of up...